DRMA - Dermata Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DRMA is currently covered by 1 analysts with an average price target of $70.74. This is a potential upside of $69.59 (6051.3%) from yesterday's end of day stock price of $1.15.

Dermata Therapeutics's activity chart (see below) currently has 3 price targets and 6 ratings on display. The stock rating distribution of DRMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 133 days.

Highest price target for DRMA is $6, Lowest price target is $6, average price target is $70.74.

Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 21-Aug-2024. First documented stock forecast 14-Sep-2021.

Best performing analysts who are covering DRMA - Dermata Therapeutics:

Anthony Vendetti Kumaraguru Raja

Currently out of the existing stock ratings of DRMA, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$4.85 (421.74%)

$16

5 months 22 days ago
(21-Aug-2024)

1/4 (25%)

$4.06 (209.28%)

266

Buy

$224

2 years 9 months 30 days ago
(14-Apr-2022)

0/1 (0%)

$135.12 (152.03%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DRMA (Dermata Therapeutics) average time for price targets to be met?

On average it took 133 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on DRMA (Dermata Therapeutics) with a proven track record?

ANTHONY VENDETTI

Which analyst has the current lower performing score on DRMA (Dermata Therapeutics) with a proven track record?

KUMARAGURU RAJA

Which analyst has the most public recommendations on DRMA (Dermata Therapeutics)?

Anthony Vendetti works at MAXIM GROUP and has 15 price targets and 10 ratings on DRMA

Which analyst is the currently most bullish on DRMA (Dermata Therapeutics)?

Anthony Vendetti with highest potential upside - $4.85

Which analyst is the currently most reserved on DRMA (Dermata Therapeutics)?

Kumaraguru Raja with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?